Belite Bio (BLTE) Other Non-Current Assets (2021 - 2026)

Belite Bio's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $289.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 5789.44% year-over-year to $289.4 million; the TTM figure through Mar 2026 stood at $289.4 million (up 5789.44% YoY), while the FY2025 annual figure was $286.3 million, up 277845.63% from the prior year.
• Other Non-Current Assets was $289.4 million for Q1 2026 at Belite Bio, up from $286.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $289.4 million in Q1 2026 to a low of $4000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $43.2 million across 5 years, with a median of $3.1 million in 2023.
• Biggest YoY gain for Other Non-Current Assets was 277845.63% in 2025; the steepest drop was 99.91% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $88000.0 in 2022, then increased by 18.18% to $104000.0 in 2023, then retreated by 0.96% to $103000.0 in 2024, then jumped by 277845.63% to $286.3 million in 2025, then advanced by 1.09% to $289.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $289.4 million (Q1 2026), $286.3 million (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.